| |
| |
| Names | |
|---|---|
| Preferred IUPAC name
2-(2,4,5-Trimethoxyphenyl)ethan-1-amine | |
| Other names
2C-O; 2C-OMe; 2,4,5-TMPEA | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C11H17NO3 | |
| Molar mass | 211.261 g·mol−1 |
| Melting point | 187 to 188 °C (369 to 370 °F; 460 to 461 K) |
| Pharmacology | |
| Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
2,4,5-Trimethoxyphenethylamine (2C-Oor2C-OMe) or is a phenethylamine of the 2C family and was first synthesized by Jansen in 1931.[1] It is a positional isomer of the drug mescaline (3,4,5-trimethoxy).
2C-O is a member of a class of chemical compounds commonly known as phenethylamines. Its full chemical name is 2-(2,4,5-trimethoxyphenyl)ethanamine; it is also known as 2,4,5-trimethoxyphenethylamine and 2,4,5-TMPEA.
Although not centrally active itself, 2C-O appeared to potentiate the action of mescaline when employed as pretreatment 45 minutes prior to the administration of mescaline.[2]
The toxicity of 2C-O is not known.
As of October 31, 2016, 2C-O is a controlled substance (Schedule III) in Canada.[3]
2C-O is a Schedule I substance, as a positional isomer of mescaline.
2C-O and all other compounds featured in PiHKAL are Class A drugs in the United Kingdom.
